首页 > 市场调查报告书 > 製药

神经疾病

市场调查报告书

商品编码

1490049

阅读障碍治疗市场：按类型、按药物类别、按分销管道、按地区

Dyslexia Treatment Market, By Type, By Drug Class, By Distribution Channel, By Geography

出版日期: 2024年05月22日 | 出版商:

Coherent Market Insights | 英文 174 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球阅读障碍治疗市场规模为75.9亿美元，2031年将达117.4亿美元，2024年至2031年复合年增长率为6.4%。

报告范围		报告详情
基准年	2023年	2024年市场规模	75.9亿美元
实际资料	2019年至2023年	预测期	从2024年到2031年
预测 2024-2031 年复合年增长率：	6.40%	2031年价值预测	117.4亿美元

图：2024 年诵读困难治疗市场占有率（%），依地区划分

阅读障碍是一种损害阅读和写作能力的学习障碍。它是一种具有很强遗传成分的神经发育障碍。阅读障碍有许多原因，包括语音处理、快速命名、工作记忆和处理速度的障碍。诵读困难症患者在准确、流利的单字辨识方面持续存在困难，且拼字和解码能力较差。全球约有 10% 至 15% 的人患有阅读障碍。透过及时诊断和适当的治疗和干预，患有阅读障碍的人可以学习策略，在阅读、写作和拼字方面更加成功。全球阅读障碍治疗市场提供评估和治疗方案，帮助阅读障碍患者提高识字能力并控制症状。

市场动态：

全球阅读障碍治疗市场的成长是由于人们对阅读障碍的认识不断提高以及对其原因和管理方法的研究不断增加而推动的。研究表明，美国有超过4000万人存在一定程度的阅读障碍，但只有10%的人接受了适当的干预服务。缺乏接受阅读障碍治疗培训的临床医生和教师可能会阻碍市场成长。此外，高昂的治疗和教育费用也是普及的障碍。然而，早期诊断、行动应用程式和提高技能的严肃游戏的先进技术的开拓可以为市场成长提供机会。旨在更好地了解阅读障碍的遗传学和神经生物学的大规模流行病学研究的投资可能会改善治疗结果。

本研究的主要特点

该报告对全球阅读障碍治疗市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数，提供全球诵读困难治疗市场主要企业的概况。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球阅读障碍治疗市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球阅读障碍治疗市场的各种策略矩阵来促进他们的决策。

公司简介
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Jubilant Pharma Limited
- GSK plc
- Eli Lilly and Company
- Otsuka Holdings Co., Ltd.
- Apotex Corporation
- Purdue Pharma
- Rhodes Pharmaceuticals LP
- Cian Healthcare Pvt. Ltd.
- Wallace Pharmaceuticals Ltd.
- The Himmel Group
- Astrazeneca
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Lupin

第10章分析师观点

Wheel of Fortune
分析师观点
Coherent Opportunity Map

第十一章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI7002

Global dyslexia treatment market is estimated to be valued at USD 7.59 Bn in 2024 and is expected to reach USD 11.74 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 7.59 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	6.40%	2031 Value Projection:	US$ 11.74 Bn

Figure. Dyslexia Treatment Market Share (%), By Region, 2024

Dyslexia is a learning disorder that impairs a person's ability to read and write. It is a neurodevelopmental disorder with a strong genetic component. There are multiple causes that contribute to dyslexia including difficulties with phonological processing, rapid naming, working memory and processing speed. It is a persistent difficulty in accurate and fluent word recognition and poor spelling and decoding abilities. Dyslexia affects approximately 10% to 15% of people worldwide. With timely diagnosis and appropriate treatment and intervention, people with dyslexia can learn strategies to read, write and spell much more successfully. Global dyslexia treatment market provides evaluation and treatment options to help dyslexic individuals achieve literacy skills and manage the symptoms.

Market Dynamics:

Global dyslexia treatment market growth is driven by growing awareness about dyslexia and increasing research on its causes and management approaches. According to studies, over 40 million people in the U.S. have some degree of dyslexia, however, only 10% receive appropriate intervention services. The shortage of trained clinicians and teachers for dyslexia treatment can hamper the market growth. High costs of therapies and education programs can also limit adoption. However, the development of advanced technologies for early diagnosis, mobile apps and serious games for skill building can provide opportunities for the market growth. Investments in large epidemiological studies that aim to better understand the genetics and neurobiology of dyslexia can improve treatment outcomes.

Key Features of the Study:

This report provides an in-depth analysis of the global dyslexia treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global dyslexia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Jubilant Pharma Limited, GSK plc, Eli Lilly and Company, Otsuka Holdings Co., Ltd., Apotex Corporation, Purdue Pharma, Rhodes Pharmaceuticals L.P., Cian Healthcare Pvt. Ltd., Wallace Pharmaceuticals Ltd., The Himmel Group, Astrazeneca, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Lupin
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global dyslexia treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dyslexia treatment market

Detailed Segmentation-

By Type:
- Phonological Dyslexia
- Surface Dyslexia
- Double Deficit Dyslexia
- Others
By Drug Class:
- Antihistamines
- Central Nervous Stimulant
- Selective Norepinephrine Reuptake Inhibitors
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Jubilant Pharma Limited
- GSK plc
- Eli Lilly and Company
- Otsuka Holdings Co., Ltd.
- Apotex Corporation
- Purdue Pharma
- Rhodes Pharmaceuticals L.P.
- Cian Healthcare Pvt. Ltd.
- Wallace Pharmaceuticals Ltd.
- The Himmel Group
- Astrazeneca
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Lupin

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Epidemiology
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Dyslexia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Dyslexia Treatment Market, By Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Phonological Dyslexia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Surface Dyslexia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Double Deficit Dyslexia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Dyslexia Treatment Market, By Drug Class, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Antihistamines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Central Nervous Stimulant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Selective Norepinephrine Reuptake Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Dyslexia Treatment Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Dyslexia Treatment Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Pfizer, Inc.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Jubilant Pharma Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Otsuka Holdings Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Apotex Corporation
- Purdue Pharma
- Rhodes Pharmaceuticals L.P.
- Cian Healthcare Pvt. Ltd.
- Wallace Pharmaceuticals Ltd.
- The Himmel Group
- Astrazeneca
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Lupin

10. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

阅读障碍治疗市场：按类型、按药物类别、按分销管道、按地区